The contrasting roles of Th17 immunity in human health and disease

被引:64
作者
Hoe, Edwin [1 ]
Anderson, Jeremy [1 ]
Nathanielsz, Jordan [1 ]
Toh, Zheng Quan [1 ]
Marimla, Rachel [1 ]
Balloch, Anne [1 ]
Licciardi, Paul V. [1 ,2 ]
机构
[1] Murdoch Childrens Res Inst, Pneumococcal Res Grp, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
关键词
autoimmune; infection; inflammation; pneumococcal; REGULATORY T-CELLS; INNATE LYMPHOID-CELLS; STREPTOCOCCUS-PNEUMONIAE; TNF-ALPHA; NASOPHARYNGEAL COLONIZATION; RHEUMATOID-ARTHRITIS; LUNG INFECTION; AUTOIMMUNE; IL-17; PROTECTION;
D O I
10.1111/1348-0421.12471
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human immune system is a tightly regulated network that protects the host from disease. An important aspect of this is the balance between pro-inflammatory Th17 cells and anti-inflammatory T regulatory (Treg) cells in maintaining immune homeostasis. Foxp3+ Treg are critical for sustaining immune tolerance through IL-10 and transforming growth factor-beta while related orphan receptor-gamma t+Th17 cells promote immunopathology and auto-inflammatory diseases through the actions of IL-17A, IL-21 and IL-22. Therefore, imbalance between Treg and Th17 cells can result in serious pathology in many organs and tissues. Recently, certain IL-17-producing cells have been found to be protective against infectious disease, particularly in relation to extracellular bacteria such Streptococcus pneumoniae; a number of other novel IL-17-secreting cell populations have also been reported to protect against a variety of other pathogens. In this mini-review, the dual roles of Treg and Th17 cells are discussed in the context of autoimmunity and infections, highlighting recent advances in the field. Development of novel strategies specifically designed to target these critical immune response pathways will become increasingly important in maintenance of human health.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 86 条
[1]   Status of research and development of pediatric vaccines for Streptococcus pneumoniae [J].
Alderson, Mark R. .
VACCINE, 2016, 34 (26) :2959-2961
[2]   Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis [J].
Astier, Anne L. ;
Meiffren, Gregory ;
Freeman, Samuel ;
Hafler, David A. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (12) :3252-3257
[3]   Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses [J].
Babb, Rachelle ;
Chen, Austen ;
Hirst, Timothy R. ;
Kara, Ervin E. ;
McColl, Shaun R. ;
Ogunniyi, Abiodun D. ;
Paton, James C. ;
Alsharifi, Mohammed .
CLINICAL SCIENCE, 2016, 130 (09) :697-710
[4]   Tr1 cells: From discovery to their clinical application [J].
Battaglia, M ;
Gregori, S ;
Bacchetta, R ;
Roncarolo, MG .
SEMINARS IN IMMUNOLOGY, 2006, 18 (02) :120-127
[5]   Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum [J].
Bendall, Sean C. ;
Simonds, Erin F. ;
Qiu, Peng ;
Amir, El-ad D. ;
Krutzik, Peter O. ;
Finck, Rachel ;
Bruggner, Robert V. ;
Melamed, Rachel ;
Trejo, Angelica ;
Ornatsky, Olga I. ;
Balderas, Robert S. ;
Plevritis, Sylvia K. ;
Sachs, Karen ;
Pe'er, Dana ;
Tanner, Scott D. ;
Nolan, Garry P. .
SCIENCE, 2011, 332 (6030) :687-696
[6]   Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells [J].
Bermejo, Daniela A. ;
Jackson, Shaun W. ;
Gorosito-Serran, Melisa ;
Acosta-Rodriguez, Eva V. ;
Amezcua-Vesely, Maria C. ;
Sather, Blythe D. ;
Singh, Akhilesh K. ;
Khim, Socheath ;
Mucci, Juan ;
Liggitt, Denny ;
Campetella, Oscar ;
Oukka, Mohamed ;
Gruppi, Adriana ;
Rawlings, David J. .
NATURE IMMUNOLOGY, 2013, 14 (05) :514-+
[7]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[8]   Therapy with anti-TNFα Antibody Enhances Number and Function of Foxp3+ Regulatory T Cells in Inflammatory Bowel Diseases [J].
Boschetti, Gilles ;
Nancey, Stephane ;
Sardi, Fatima ;
Roblin, Xavier ;
Flourie, Bernard ;
Kaiserlian, Dominique .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) :160-170
[9]   Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases [J].
Buckner, Jane Hoyt .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (12) :849-859
[10]   Phenotypical and functional specialization of FOXP3+ regulatory T cells [J].
Campbell, Daniel J. ;
Koch, Meghan A. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :119-130